The following commentary comes from an independent investor or market observer as part of TheStreet's guest contributor program, which is separate from the company's news coverage.
NEW YORK (
is a pretty impressive mutual fund manager. We analyzed Berkowitz's returns using Carhart's four-factor model and determined that
Berkowitz had an average annual alpha
of three percentage points per year. Usually, mutual funds try to extract every drop of alpha in their successful strategies by expanding their assets and buying index stocks. They keep making money through management fees but their clients couldn't enjoy any alpha for long periods of time.
Berkowitz is different, and that's why we follow his moves.
Berkowitz filed his 13F form with the SEC this week and disclosed three new positions, one of which is truly new.
initiated a $614 million position in
(CSCO - Get Report) during the first quarter. Fairholme also sold its entire $1.75 billion
General Growth Properties
(GGP - Get Report) stake and initiated an $892 million
Brookfield Asset Management
(BAM - Get Report) position. Unfortunately, Fairholme lost nearly $1 billion because of the decline in
(AIG) shares. This decline prompted Berkowitz to spend an additional $264 million on AIG warrants.
Berkowitz also initiated five other new but very small positions in
(TEF - Get Report),
(LLY - Get Report),
(BMY - Get Report),
(AZN). Fairholme sold out its stake in
Wellcare Health Plans
Several hedge funds got rid of their CSCO bets during the first quarter as the company kept disappointing.
David Tepper's Appaloosa
Larry Robbins' Glenview Capital,
Alan Fournier's Pennant Capital
sold their entire CSCO stakes.
Phill Gross' Adage
reduced its holdings by nearly 10%. On the opposite side of the trade were
The table below provides a summary of Berkowitz's portfolio activity during the first quarter:
This was originally published on Insider Monkey.
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts